Case reports have shown that the use of ACE inhibitors promotes OSA-like symptoms, such as nasal obstruction, snoring, daytime sleepiness, and witness sleep apnea [15], and reduces CPAP adherence [16] in patients with ACE inhibitor-related cough, but not in patients with good tolerance for ACE inhibitors. This evidence concerns the gene ACE and obstructive sleep apnea syndrome.